Integral Diagnostics (ASX:IDX) reported Wednesday attributable loss per diluted share in the fiscal first half narrowed to AU$0.0016, from a loss of AU$0.2862 per diluted share a year earlier.
Analysts polled by Visible Alpha were expecting earnings per share of AU$0.0006.
Revenue from ordinary activities for the six months Dec. 31, 2024, was AU$252.9 million, up 9% from AU$231.3 million in the same period last year. Analysts surveyed by Visible Alpha expected AU$250.6 million.
The radiologist and diagnostic imaging provider replacement and growth capital expenditure for the fiscal year to reach AU$60 million to AU$65 million.
The board declared an interim dividend of AU$0.025 per share, unchanged from the previous reported period, payable on April 7 to shareholders on record as of March 7.
Price (AUD): $2.86, Change: $-0.030, Percent Change: -1.04%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。